Recombinant

Type: Keyphrase
Name: Recombinant
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Evaluation of Unintended Effects in the Composition of Tomatoes Expressing a Human Immunoglobulin A against Rotavirus

The production of neutralizing immunoglobulin A (IgA) in edible fruits as a means of oral passive immunization is a promising strategy for the inexpensive treatment of mucosal diseases. This approach is based on the assumption that the edible status remains ... [Published Journal of Agricultural and Food Chemistry - 6 hours ago]
First reported 12 hours ago - Updated 10 hours ago - 1 reports

Two companies submit ‘breakthrough’ meningitis B vaccines for approval

On June 17, both Novartis and Pfizer submitted Biologics License Applications to FDA for marketing approval of meningitis B vaccines for use in patients aged 10 years to 25 years. Novartis’s multicomponent meningococcal group B vaccine, recombinant adsorbed ... [Published Pharmacist.com - 12 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Occurrence of Glycosidically Conjugated 1-Phenylethanol and Its Hydrolase β-Primeverosidase in Tea (Camellia sinensis) Flowers

A previous study found that 1-phenylethanol (1PE) was a major endogenous volatile compound in tea (Camellia sinensis) flowers and can be transformed to glycosically conjugated 1PE (1PE-Gly). However, occurrences of 1PE-Gly in plants remain unknown. In ... [Published Journal of Agricultural and Food Chemistry - 10 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

FDA Advisors Give ‘Thumbs Up’ to Immune Therapy HyQvia

News Categories Approval decision expected in third quarter of 2014The FDA’s Blood Products Advisory Committee (BPAC) has voted 15 to 1 that HyQvia (immunoglobulin infusion 10% [human] with recombinant human hyaluronidase, Baxter International/Halozyme ... [Published PT Community - 11 hours ago]
First reported Jul 31 2014 - Updated 16 hours ago - 1 reports

FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency

Baxter International Inc. ( NYSE:BAX ) and Halozyme Therapeutics, Inc.,( NASDAQ:HALO ) today announced that the Blood Products Advisory Committee(BPAC) of the U.S. Food and Drug Administration (FDA) voted 15-1 thatHyQvia [Immune Globulin Infusion 10% ... [Published Minyanville - Jul 31 2014]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Baxter International Inc. (BAX) - Product Pipeline Analysis, 2014 Update - New Market Study Published

Boston, MA -- (SBWIRE) -- 08/01/2014 -- Baxter International Inc. (Baxter) is a diversified global healthcare company. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients ... [Published RCL Advisors - 17 hours ago]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

outdoor cat

Dogs have long had options for the three year rabies vaccines. Now that option will be available for cats too through Merial's PureVax Feline Rabies Vaccine. This is a nonadjuvanted vaccine using canary pox recombinant techniques.Nonadjuvanted means the ... [Published Examiner.com - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 2 reports

Pharming Reports On Financial Results First Half Year 2014

Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) today published its financial report for the six months ended 30 June 2014.On July 16, 2014, the US FDA approved Ruconest® for the treatment of angioedema attacks in ... [Published Pharming - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

On the Road: The Evolution of HIV Along Highway Networks

Just as we jetsetters and nomads wander the wide world’s winding roads and byways by foot, on horseback, atop a bicycle or packed into an automobile, so too do infectious diseases make use of our ever-improving networks of thoroughfares. They ride along ... [Published Discover Magazine - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Ad Comm votes 15-1 in favor of HyQvia

The FDA's Blood Products Advisory Committee votes 15-1 supporting the risk/benefit profile of HyQvia [Immune Globulin 10% (Human) with Recombinant Human Hyaluronidase]. The product was approved in Europe in 2013 for the treatment of adult patients with ... [Published Seeking Alpha - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Dompe announces the Food and Drug Administration FDA has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis

By a News Reporter-Staff News Editor at Biotech Week -- Dompe, a leader in R&D for new therapeutic solutions for the treatment of rare diseases, announces that rhNGF (Recombinant Human Nerve Growth Factor) has been designated as an orphan drug by the ... [Published HispanicBusiness.com - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

BIOMARIN PHARMACEUTICAL : Patent Issued for Formulations for Lysosomal Enzymes

By a News Reporter-Staff News Editor at Biotech Week -- Biomarin Pharmaceutical Inc. ( Novato, CA ) has been issued patent number 8785168, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Biomarin Pharmaceutical ... [Published 4 Traders - Jul 31 2014]

Quotes

Ricroch AE: Assessment of GE food safety using "-omics’ techniques and long-term animal feeding studies. N Biotechnol 2012, 30:349-354. PubMed Abstract"
"If it's a fad, then why have over 60 countries around the world adopted it?" Solheim asked. "I don't think it's a fad that people want to know what's in their food."
...Wheeler. "We are working towards several milestones that are indicative of our operational progress: we are advancing toward a regulatory submission of our lead biosimilars program M923 by the end of 2014, and expect to achieve a development milestone on M834 in the second half of 2014 as well. In addition, we expect to complete the Part A study of our necuparanib (M402) program shortly, with data available later this year and plan to initiate the Part B study by the end of the year."
). The Journal of Neurosurgery is pleased to announce today's publication of a supplement to the August issue entitled "Race Against the Clock: Overcoming Challenges in the Management of Anticoagulant-Associated Intracerebral Hemorrhage." Authored by Peter Le Roux, MD, Charles V Pollack, Jr...

More Content

All (1320) | News (989) | Reports (0) | Blogs (269) | Audio/Video (0) | Fact Sheets (14) | Press Releases (36)
sort by: Date | Relevance
GMOs in animal agriculture: time to consider bo... [Published GMOAnswers - 1 hour ago]
SANOFI : Jean-Laurent Casanova Honored with 201... [Published 4 Traders - 1 hour ago]
Evaluation of Unintended Effects in the Compos... [Published Journal of Agricultural and Food Chemistry - 6 hours ago]
Ben & Jerry's still fights GMOs [Published Columbian.com - 6 hours ago]
Momenta Pharmaceuticals Reports Second Quarter ... [Published Pharmacy Choice - 9 hours ago]
Occurrence of Glycosidically Conjugated 1-Phen... [Published Journal of Agricultural and Food Chemistry - 10 hours ago]
FDA Advisors Give ‘Thumbs Up’ to Immune Therapy... [Published PT Community - 11 hours ago]
Enhanced Healing of Rat Calvarial Defects with ... [Published Plosone.org - 11 hours ago]
Two companies submit ‘breakthrough’ meningitis ... [Published Pharmacist.com - 12 hours ago]
Management of Anticoagulant-associated Intracer... [Published ScienceNewsline - 12 hours ago]
Astellas Pharma's (ALPMF) Q2 2014 Results - Ear... [Published Seeking Alpha - 13 hours ago]
Anti-inflammatory protein “rheostat” sheds ligh... [Published Noodls - 15 hours ago]
FDA panel green-lights Baxter and Halozyme's dr... [Published FierceBiotech - 16 hours ago]
Baxter International Inc. (BAX) - Product Pipel... [Published RCL Advisors - 17 hours ago]
Baxter International Inc. (BAX) - Product Pipel... [Published SBWire - 17 hours ago]
Pink1, the first ubiquitin kinase [Published EMBO Journal - 17 hours ago]
Kyowa Hakko Kirin files for KW-3357 approval in... [Published Pharma Letter - 18 hours ago]
Soligenix Receives Additional NIAID Funding to ... [Published Pettinga Financial Advisors - 19 hours ago]
New supplement covers current knowledge and met... [Published News-Medical.Net - 21 hours ago]
Management of anticoagulant-associated intracer... [Published EurekAlert! - 22 hours ago]
Creative Diagnostics Expands Database of Antibo... [Published PR.com Press Releases - Aug 01 2014]
Showcase, August 2014 [Published Pharmacist.com - Aug 01 2014]
Non-fatal case of Crimean-Congo haemorrhagic fe... [Published Eurosurveillance - Aug 01 2014]
Kyowa Hakko Kirin Submits Application for Appro... [Published Kyowa Kirin - Aug 01 2014]
AstraZeneca Group's (AZN) CEO Pascal Soriot on ... [Published Seeking Alpha - Aug 01 2014]
ICMR to collaborate with private cos to commerc... [Published PharmaBiz - Aug 01 2014]
Are testicular mast cells involved in the regul... [Published UroToday - Aug 01 2014]
Nektar Therapeutics' (NKTR) CEO Howard Robin on... [Published Seeking Alpha - Aug 01 2014]
Vaccine for the treatment of Mycobacterium rela... [Published PharmCast - Aug 01 2014]
outdoor cat [Published Examiner.com - Aug 01 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Creative Diagnostics Expands Database of Antibo... [Published PR.com Press Releases - Aug 01 2014]
New York, NY, August 01, 2014 --( PR.com )-- Researchers from Creative Diagnostics have developed a more efficient workflow to manufacture and optimize the process of antibody pair production. On the basis, Creative Diagnostics is able to shorten the ...
Company Offering Open-Source Biological Reagent... [Published Techdirt - Jul 30 2014]
It's well-known that monopolies can lead to price-gouging, which produces effects like this: I still have no idea how people can get away with charging several thousand dollars for a milligram of recombinant protein. That's an amount that you can see ...
Finally, A Biosimilar Application Has Been Acce... [Published Patent Docs - Jul 29 2014]
By Andrew Williams -- In what is thought to be the first application accepted under the new biosimilar pathway created by the Biologics Price Competition and Innovation (BPCI) Act, Sandoz announced last Thursday that the U.S. Food and Drug Administration ...
Upcoming AdComms By Subject Matter [Published Eye on FDA - Jul 28 2014]
In February and in April I posted a listing of upcoming advisory committees by subject matter and people seemed to like this way of looking at it, so I try to repeat it every so often.  Today is every so often.  It is just a different way of ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Jul 28 2014]
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Novavax to Host Conference Call to Discuss Seco... [Published GlobeNewswire: Acquisitions News - Jul 30 2014]
Novavax Recognized as One of The Washington Pos... [Published GlobeNewswire: Advertising News - Jun 23 2014]
Versartis Appoints Endocrinologist Bert Bakker,... [Published GlobeNewswire: Advertising News - Jun 23 2014]
Novavax Announces Management Promotions [Published GlobeNewswire: Agriculture News - Jun 19 2014]
Long-Time Novavax Board Member Jack Marsh Assum... [Published GlobeNewswire: Advertising News - Jun 18 2014]
1 2 3 4 5 6 7 8
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.